Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

Similar articles for PubMed (Select 22995028)

1.

Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.

Yamashita A, Shiraga F, Shiragami C, Shirakata Y, Fujiwara A.

Am J Ophthalmol. 2013 Jan;155(1):96-102.e1. doi: 10.1016/j.ajo.2012.06.027. Epub 2012 Sep 18.

PMID:
22995028
2.

One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.

Yamashita A, Shiraga F, Shiragami C, Ono A, Tenkumo K.

Am J Ophthalmol. 2010 Mar;149(3):465-71.e1. doi: 10.1016/j.ajo.2009.09.020. Epub 2009 Dec 30.

PMID:
20042180
3.

Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.

Sagong M, Lim S, Chang W.

Am J Ophthalmol. 2012 May;153(5):873-882.e2. doi: 10.1016/j.ajo.2011.09.031. Epub 2012 Jan 20.

PMID:
22265146
4.

Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.

Kang HM, Kim YM, Koh HJ.

Am J Ophthalmol. 2013 Mar;155(3):438-447.e1. doi: 10.1016/j.ajo.2012.09.020. Epub 2012 Dec 4.

PMID:
23218705
5.

Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.

Tomita K, Tsujikawa A, Yamashiro K, Ooto S, Tamura H, Otani A, Nakayama Y, Yoshimura N.

Am J Ophthalmol. 2012 Jan;153(1):68-80.e1. doi: 10.1016/j.ajo.2011.07.001. Epub 2011 Sep 9.

PMID:
21907965
6.

Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.

Ricci F, Calabrese A, Regine F, Missiroli F, Ciardella AP.

Retina. 2012 Jul;32(7):1280-8. doi: 10.1097/IAE.0b013e318236e835.

PMID:
22218148
7.

Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.

Otani A, Sasahara M, Yodoi Y, Aikawa H, Tamura H, Tsujikawa A, Yoshimura N.

Am J Ophthalmol. 2007 Jul;144(1):7-14. Epub 2007 Apr 30.

PMID:
17467649
8.

Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.

Gomi F, Sawa M, Wakabayashi T, Sasamoto Y, Suzuki M, Tsujikawa M.

Am J Ophthalmol. 2010 Jul;150(1):48-54.e1. doi: 10.1016/j.ajo.2010.02.008.

PMID:
20609707
9.

Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.

Lee YH, Lee EK, Shin KS, Lee KM, Kim JY.

Retina. 2011 Jul-Aug;31(7):1287-93. doi: 10.1097/IAE.0b013e3182003ccd.

PMID:
21386762
10.
11.

Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy.

Gemmy Cheung CM, Yeo I, Li X, Mathur R, Lee SY, Chan CM, Wong D, Wong TY.

Am J Ophthalmol. 2013 Feb;155(2):295-304.e1. doi: 10.1016/j.ajo.2012.08.002. Epub 2012 Oct 27.

PMID:
23111181
12.

Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.

Lai TY, Lee GK, Luk FO, Lam DS.

Retina. 2011 Sep;31(8):1581-8. doi: 10.1097/IAE.0b013e31820d3f3f.

PMID:
21610566
13.

Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.

Hikichi T, Ohtsuka H, Higuchi M, Matsushita T, Ariga H, Kosaka S, Matsushita R, Takami K.

Am J Ophthalmol. 2010 Nov;150(5):674-682.e1. doi: 10.1016/j.ajo.2010.05.026. Epub 2010 Aug 5.

PMID:
20691424
14.

Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up.

Lee YA, Yang CH, Yang CM, Ho TC, Lin CP, Huang JS, Chen MS.

Am J Ophthalmol. 2012 Nov;154(5):872-880.e2. doi: 10.1016/j.ajo.2012.03.051. Epub 2012 Jul 24.

PMID:
22831838
15.

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH.

Ophthalmology. 2004 Aug;111(8):1576-84.

PMID:
15288991
16.

One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.

Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y.

Ophthalmology. 2008 Jan;115(1):141-6. Epub 2007 Jun 20.

PMID:
17582498
17.

Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.

Moon SW, Kim MS, Kim ES, Yu SY, Kwak HW.

Ophthalmologica. 2011;225(3):169-75. doi: 10.1159/000323811. Epub 2011 Jan 27.

PMID:
21273795
18.

Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.

Saito M, Iida T, Kano M, Itagaki K.

Graefes Arch Clin Exp Ophthalmol. 2014 Feb;252(2):227-35. doi: 10.1007/s00417-013-2433-1. Epub 2013 Aug 7.

PMID:
23918094
19.

Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.

Kurashige Y, Otani A, Sasahara M, Yodoi Y, Tamura H, Tsujikawa A, Yoshimura N.

Am J Ophthalmol. 2008 Oct;146(4):513-519. doi: 10.1016/j.ajo.2008.05.025. Epub 2008 Jul 9.

PMID:
18614133
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk